Concepedia

Brandon D’Arcy

BD

Statistics

Publications

4

Citations

163

H-Index

4

Active since

2016

Affiliations

University of South Alabama(Current)

Dartmouth College

USA Mitchell Cancer Institute

Brandon D’Arcy is an author at University of South Alabama specializing in pharmacology, threonine protein phosphatases, and enzyme inhibition.

Publications per year

2016–2019

4

Publications

4

The Antitumor Drug LB-100 Is a Catalytic Inhibitor of Protein Phosphatase 2A (PPP2CA) and 5 (PPP5C) Coordinating with the Active-Site Catalytic Metals in PPP5C

Brandon D’Arcy, Mark R. Swingle, Cinta M. Papke et al. · Molecular Cancer Therapeutics · 2019 · 68 citations

Medicine, Oncology, Pharmacology +11

PP1:Tautomycetin Complex Reveals a Path toward the Development of PP1-Specific Inhibitors

M.S. Choy, Mark R. Swingle, Brandon D’Arcy et al. · Journal of the American Chemical Society · 2017 · 56 citations · Full text

Life Sciences, Biochemistry, Pharmacology +13

Crystal structures and mutagenesis of PPP-family ser/thr protein phosphatases elucidate the selectivity of cantharidin and novel norcantharidin-based inhibitors of PP5C

Debasish Chattopadhyay, Mark R. Swingle, E. Alan Salter et al. · Biochemical Pharmacology · 2016 · 29 citations · Full text

Life Sciences, Biochemistry, Pharmacology +12

Biochemical and structural characterization of two variants of uncertain significance in the <i>PMS2</i> gene

Brandon D’Arcy, Jessa Blount, Aishwarya Prakash · Human Mutation · 2019 · 10 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

1–4 of 4